Short answer · Medically reviewed summary · Last updated: 2026-05-08
Medullary Sponge Kidney (MSK) is a congenital disorder characterized by cystic dilation of the renal collecting ducts, primarily managed through metabolic stone prevention. Recent research is shifting from purely symptomatic treatment toward understanding the genetic basis of Medullary Sponge Kidney and identifying potential biomarkers to predict disease progression and stone formation risk. What are the current research directions for Medullary Sponge Kidney? Current research into Medullary Sponge Kidney is focused on identifying the genetic markers that contribute to its development.
6 people with Medullary Sponge Kidney have shared their first-person experience on this question at DiseaseMaps.
What are the latest advances in Medullary Sponge Kidney?
Latest advances in Medullary Sponge Kidney: recent research, treatments in development and what they could mean, with sources.
Medullary Sponge Kidney (MSK) is a congenital disorder characterized by cystic dilation of the renal collecting ducts, primarily managed through metabolic stone prevention. Recent research is shifting from purely symptomatic treatment toward understanding the genetic basis of Medullary Sponge Kidney and identifying potential biomarkers to predict disease progression and stone formation risk.
What are the current research directions for Medullary Sponge Kidney?
Current research into Medullary Sponge Kidney is focused on identifying the genetic markers that contribute to its development. While Medullary Sponge Kidney is often considered a sporadic condition, studies are investigating potential associations with developmental genes like GDNF. Researchers are also working to better characterize the link between Medullary Sponge Kidney and hypercalciuria, aiming to refine personalized metabolic therapies that can reduce the high recurrence rate of nephrolithiasis (kidney stones) in these patients.
Are there new diagnostic tools for Medullary Sponge Kidney?
Advancements in diagnostic imaging, particularly high-resolution CT urography, have improved the detection of Medullary Sponge Kidney by allowing clinicians to visualize the characteristic "paintbrush" appearance of the renal papillae more clearly. Researchers are exploring non-invasive urinary biomarkers that could help distinguish Medullary Sponge Kidney from other forms of cystic kidney disease, potentially reducing the need for repeated radiation exposure from imaging.
What is the status of clinical trials and registries?
While no curative drug therapy currently exists for Medullary Sponge Kidney, patient-centered research is expanding. The community at DiseaseMaps.org, which currently includes 347 members living with Medullary Sponge Kidney, provides vital observational data that helps researchers understand the real-world impact of the condition. Ongoing efforts include:
- Genetic Mapping: Investigating the familial clustering of Medullary Sponge Kidney to identify susceptibility loci.
- Metabolic Databases: Tracking long-term outcomes of patients with Medullary Sponge Kidney to optimize hydration and dietary protocols.
- Clinical Trial Registries: Monitoring clinicaltrials.gov for studies focusing on secondary hyperparathyroidism or chronic kidney disease management in Medullary Sponge Kidney populations.
Next steps
- Consult a nephrologist specializing in stone disease to discuss the latest metabolic management guidelines for Medullary Sponge Kidney.
- Join the Medullary Sponge Kidney community at DiseaseMaps.org to connect with others and share experiences.
- Search ClinicalTrials.gov using the term "Medullary Sponge Kidney" to stay informed on emerging research opportunities.
Medical disclaimer: This information is for educational purposes only and does not constitute medical advice; always consult with a qualified healthcare professional regarding your specific diagnosis and treatment plan.
References
- NIH Genetic and Rare Diseases Information Center (GARD): Medullary Sponge Kidney
- Orphanet: Medullary Sponge Kidney (ORPHA:2451)
- OMIM (Online Mendelian Inheritance in Man): Medullary Sponge Kidney (#174000)
- PubMed: Recent clinical reviews on cystic renal disorders and nephrolithiasis management.
Posted May 21, 2017 by Brooke 2100
Posted May 24, 2017 by Angel 2290
Posted Jun 17, 2017 by SaraKay423 2170
Posted May 27, 2018 by Cecilia 4100
Surgery for specific complications due to MSK
Ureteroscopic holmium laser lithotripsy and papillotomy is also referred to as a “Kidney Clean Out” for those with Cacchi-Ricci Disease.
Posted Jul 31, 2018 by Shannon Bauer 4190
He said it’s autosomal dominant, one copy can cause MSK but to a lesser degree. 2 copies and you have chronic issues. I have two copies, and he theorized both my grandparents did too based off family history. I have over 20 stones in each kidney and had one become embedded in my ureter, after 9 surgeries and procedures I had a partial ureterectomy and now my bladder is smaller and higher up.
MSK causes fluid to move quickly thru without filtering properly bc of the cysts and stones, which causes stagnation within the cysts which then causes stones to form (in some - likely in those with 2 copies).
Best thing to drink is coffee. It forces the kidneys to work and filters quickly, and in kidneys that move water thru too quickly to filter like with MSK, it makes you actually filter better. As best as you can at least. Moving and filtering quicker means less stagnation so less utis and stones. And of course follow the diet for the particular stone type you have.
Posted Feb 1, 2019 by Hilary 200
